Tagged with

What attracted you to IMS Health? I was most attracted by the fact that IMS is able to actually change healthcare systems. I think IMS is a very important player throughout the world in terms of not only providing information to different players within the healthcare system but also trying…

Can you please introduce yourself and Arthur Cox’s life science practice to our readers? I am a partner within the technology and life sciences group at Arthur Cox, and head of our life sciences team. I joined the firm in January of 1999, shortly following qualification. I have been with…

Can you give a brief summary of how Intercell started, how it developed and where it stands today? Intercell was created in 1997 as a spinoff from Vienna University. From the beginning, Intercell’s mission was to develop innovative vaccines to prevent and treat infectious diseases. It started primarily with two…

The company was founded in 1853 by Franz Johann Kwizda. Almost 160 years later, we are here with a very different company operating in a different context; but can we say that the company today reflects the early vision Mr Franz Johann Kwizda had at its creation? Indeed; Kwizda today…

Let’s start by introducing our readers to the Austrian affiliate of Cegedim. Can you summarize Cegedim scope of activities and operations in Austria, as well as the structure of this particular affiliate? Cegedim Austria was founded in 2001 after obtaining our initial client, and the affiliate has been growing consistently…

In your opinion, what have been the most important developments of the healthcare market in Austria over the last three years? To start with, even though we are a national competent authority , regulating medicinal products and medical devices is not only a national responsibility: whatever we do, we need…

Mr. Cooke, you joined Alkermes after the company acquired the Elan Drug Technologies (EDT) unit in 2011—a unit you headed for four years. Can you please begin by introducing yourself to our readers, and explain the rationale and outcomes of the merger? I was born in Dublin, earned my degree…

Mr. Somers, can you please introduce us to the Helsinn Group and its unique in-licensing model? Helsinn is a Swiss-based, private company owned by the Braglia family. The Braglias have been in the pharmaceutical business since the late 1930’s. The current company, incorporated as Helsinn, is about 35 years old,…

Mylan embarked upon its first major international expansion program in 2007, after the acquisition of Merck KGaA’s generic medicines business. How has the organization subsequently evolved in the UK/Ireland market and in Ireland in particular? John Munson: In 2007, Mylan actually made two acquisitions: Matrix Laboratories, one of the world’s…

In three months you will be celebrating two years as the head of Takeda Colombia. Your two major objectives were to set up the Andean cluster (Colombia, Ecuador, Peru, and Venezuela) and leading the takeover of Farmacol as a door opener to Colombia”. Where are you standing today and what…

Despite its diminutive size, the Netherlands has historically carried a large weight in the world because of certain cultural endowments: small but united, entrepreneurial, innovative, and externally oriented. During the Dutch Golden Age, the “low country” monopolized international trade and commerce giving rise to tulip manias, artistic masters, and the…

Mr. Keogh, you founded Millmount Healthcare in 1999. What was the vision behind the company? Prior to founding Millmount, I spent ten years in pharmaceutical manufacturing and contract packaging in the UK. I worked for innovator companies, and I worked for contract packing houses—and I saw a huge disparity between…